SHARPS TECHNOLOGY INC (STSS) Fundamental Analysis & Valuation

NASDAQ:STSS • US82003F3091

1.79 USD
-0.06 (-3.24%)
At close: Mar 6, 2026
1.7719 USD
-0.02 (-1.01%)
After Hours: 3/6/2026, 8:00:00 PM

This STSS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Overall STSS gets a fundamental rating of 1 out of 10. We evaluated STSS against 184 industry peers in the Health Care Equipment & Supplies industry. STSS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. STSS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. STSS Profitability Analysis

1.1 Basic Checks

  • In the past year STSS has reported negative net income.
  • In the past year STSS has reported a negative cash flow from operations.
  • In the past 5 years STSS always reported negative net income.
  • STSS had a negative operating cash flow in each of the past 5 years.
STSS Yearly Net Income VS EBIT VS OCF VS FCFSTSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

  • With a Return On Assets value of -23.51%, STSS perfoms like the industry average, outperforming 48.37% of the companies in the same industry.
  • STSS has a Return On Equity (-24.09%) which is in line with its industry peers.
Industry RankSector Rank
ROA -23.51%
ROE -24.09%
ROIC N/A
ROA(3y)-83.26%
ROA(5y)-86.74%
ROE(3y)-212.63%
ROE(5y)-179.23%
ROIC(3y)N/A
ROIC(5y)N/A
STSS Yearly ROA, ROE, ROICSTSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

  • STSS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STSS Yearly Profit, Operating, Gross MarginsSTSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

4

2. STSS Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, STSS has more shares outstanding
  • STSS has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for STSS is higher compared to a year ago.
STSS Yearly Shares OutstandingSTSS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2K 4K 6K
STSS Yearly Total Debt VS Total AssetsSTSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • STSS has an Altman-Z score of 1.78. This is a bad value and indicates that STSS is not financially healthy and even has some risk of bankruptcy.
  • STSS has a Altman-Z score (1.78) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.02 indicates that STSS is not too dependend on debt financing.
  • The Debt to Equity ratio of STSS (0.02) is better than 71.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 1.78
ROIC/WACCN/A
WACCN/A
STSS Yearly LT Debt VS Equity VS FCFSTSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

  • A Current Ratio of 3.74 indicates that STSS has no problem at all paying its short term obligations.
  • The Current ratio of STSS (3.74) is better than 64.67% of its industry peers.
  • STSS has a Quick Ratio of 3.67. This indicates that STSS is financially healthy and has no problem in meeting its short term obligations.
  • STSS has a better Quick ratio (3.67) than 72.28% of its industry peers.
Industry RankSector Rank
Current Ratio 3.74
Quick Ratio 3.67
STSS Yearly Current Assets VS Current LiabilitesSTSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

0

3. STSS Growth Analysis

3.1 Past

  • STSS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.59%, which is quite impressive.
EPS 1Y (TTM)72.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-633.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-95.06%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STSS Yearly Revenue VS EstimatesSTSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 10B 20B 30B
STSS Yearly EPS VS EstimatesSTSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 -1K -2K -3K -4K

0

4. STSS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for STSS. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STSS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STSS Price Earnings VS Forward Price EarningsSTSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STSS Per share dataSTSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. STSS Dividend Analysis

5.1 Amount

  • STSS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

STSS Fundamentals: All Metrics, Ratios and Statistics

SHARPS TECHNOLOGY INC

NASDAQ:STSS (3/6/2026, 8:00:00 PM)

After market: 1.7719 -0.02 (-1.01%)

1.79

-0.06 (-3.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-23
Earnings (Next)N/A
Inst Owners10.71%
Inst Owner Change163.65%
Ins Owners0.13%
Ins Owner Change0%
Market Cap51.91M
Revenue(TTM)2.51M
Net Income(TTM)-104.37M
Analysts82.86
Price Target22.44 (1153.63%)
Short Float %1.88%
Short Ratio0.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-99.64%
Min Revenue beat(2)-99.91%
Max Revenue beat(2)-99.36%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20.67
P/FCF N/A
P/OCF N/A
P/B 0.12
P/tB 0.12
EV/EBITDA N/A
EPS(TTM)-689.83
EYN/A
EPS(NY)-1.12
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS0.09
BVpS14.94
TBVpS14.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -23.51%
ROE -24.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-83.26%
ROA(5y)-86.74%
ROE(3y)-212.63%
ROE(5y)-179.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 568.11%
Cap/Sales 138.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.74
Quick Ratio 3.67
Altman-Z 1.78
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)192.36%
Cap/Depr(5y)2248.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.86%
EPS Next Y-633.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-95.06%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1342.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-55.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65.07%
OCF growth 3YN/A
OCF growth 5YN/A

SHARPS TECHNOLOGY INC / STSS FAQ

What is the fundamental rating for STSS stock?

ChartMill assigns a fundamental rating of 1 / 10 to STSS.


What is the valuation status of SHARPS TECHNOLOGY INC (STSS) stock?

ChartMill assigns a valuation rating of 0 / 10 to SHARPS TECHNOLOGY INC (STSS). This can be considered as Overvalued.


What is the profitability of STSS stock?

SHARPS TECHNOLOGY INC (STSS) has a profitability rating of 1 / 10.


How financially healthy is SHARPS TECHNOLOGY INC?

The financial health rating of SHARPS TECHNOLOGY INC (STSS) is 4 / 10.